{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T16:06:05Z","timestamp":1776701165444,"version":"3.51.2"},"reference-count":54,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T00:00:00Z","timestamp":1715904000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["SB\/S2\/JCB-41\/2013"],"award-info":[{"award-number":["SB\/S2\/JCB-41\/2013"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["PR32713"],"award-info":[{"award-number":["PR32713"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/V001329\/1"],"award-info":[{"award-number":["MR\/V001329\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["mx28534"],"award-info":[{"award-number":["mx28534"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/RLF\/Reentry\/09\/2019"],"award-info":[{"award-number":["BT\/RLF\/Reentry\/09\/2019"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004167","name":"Medicines for Malaria Venture","doi-asserted-by":"publisher","award":["P020\/00065"],"award-info":[{"award-number":["P020\/00065"]}],"id":[{"id":"10.13039\/501100004167","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.isci.2024.110049","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T01:12:02Z","timestamp":1716340322000},"page":"110049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["ATP mimetics targeting prolyl-tRNA synthetases as a new avenue for antimalarial drug development"],"prefix":"10.1016","volume":"27","author":[{"given":"Siddhartha","family":"Mishra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nipun","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beno\u00eet","family":"Laleu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumyananda","family":"Chakraborti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manickam","family":"Yogavel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3305-0034","authenticated-orcid":false,"given":"Amit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2024.110049_bib1","year":"2023","journal-title":"World Malaria Report"},{"key":"10.1016\/j.isci.2024.110049_bib2","doi-asserted-by":"crossref","first-page":"14962","DOI":"10.1074\/jbc.RA118.004558","article-title":"Structure of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase-dihydropteroate synthase from Plasmodium vivax sheds light on drug resistance","volume":"293","author":"Yogavel","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2024.110049_bib3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijpddr.2019.10.001","article-title":"Profiles of Kelch mutations in Plasmodium falciparum across South Asia and their implications for tracking drug resistance","volume":"11","author":"Chhibber-Goel","year":"2019","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.isci.2024.110049_bib4","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","article-title":"Evidence of Artemisinin-Resistant Malaria in Africa","volume":"385","author":"Balikagala","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2024.110049_bib5","doi-asserted-by":"crossref","unstructured":"Rosenthal PJ. Has artemisinin resistance emerged in Africa? Lancet Infect Dis. 2021 Aug;21(8):1056-1057. doi: 10.1016\/S1473-3099(21)00168-7. Epub 2021 Apr 14. PMID: 33864802.","DOI":"10.1016\/S1473-3099(21)00168-7"},{"key":"10.1016\/j.isci.2024.110049_bib6","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.drudis.2018.01.050","article-title":"Drug targeting of one or more aminoacyl-tRNA synthetase in the malaria parasite Plasmodium falciparum","volume":"3","author":"Manickam","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.isci.2024.110049_bib7","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1186\/1471-2164-10-644","article-title":"A genomic glimpse of aminoacyl-tRNA synthetases in malaria parasite Plasmodium falciparum","volume":"10","author":"Bhatt","year":"2009","journal-title":"BMC Genom."},{"key":"10.1016\/j.isci.2024.110049_bib8","doi-asserted-by":"crossref","first-page":"102860","DOI":"10.1016\/j.jbc.2022.102860","article-title":"Exploration of aminoacyl-tRNA synthetases from eukaryotic parasites for drug development","volume":"299","author":"Gill","year":"2023","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2024.110049_bib9","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.str.2012.07.011","article-title":"Distinct states of methionyl-tRNA synthetase indicate inhibitor binding by conformational selection","volume":"20","author":"Koh","year":"2012","journal-title":"Structure"},{"key":"10.1016\/j.isci.2024.110049_bib10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.molbiopara.2013.04.007","article-title":"Crystal structures of Plasmodium falciparum cytosolic tryptophanyl-tRNA synthetase and its potential as a target for structure-guided drug design","volume":"189","author":"Koh","year":"2013","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.isci.2024.110049_bib11","doi-asserted-by":"crossref","first-page":"e2775","DOI":"10.1371\/journal.pntd.0002775","article-title":"Structures of Trypanosoma brucei Methionyl-tRNA Synthetase with Urea-Based Inhibitors Provide Guidance for Drug Design against Sleeping Sickness","volume":"8","author":"Koh","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.isci.2024.110049_bib12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nchembio.790","article-title":"Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase","volume":"8","author":"Keller","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.isci.2024.110049_bib13","doi-asserted-by":"crossref","first-page":"288ra77","DOI":"10.1126\/scitranslmed.aaa3575","article-title":"The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs","volume":"7","author":"Herman","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2024.110049_bib14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10969-014-9186-x","article-title":"Structural and functional analysis of the anti-malarial drug target prolyl-tRNA synthetase","volume":"15","author":"Jain","year":"2014","journal-title":"J.\u00a0Struct. Funct. Genomics"},{"key":"10.1016\/j.isci.2024.110049_bib15","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.str.2015.02.011","article-title":"Structure of prolyl-tRNA synthetase-halofuginone complex provides basis for development of drugs against malaria and toxoplasmosis","volume":"23","author":"Jain","year":"2015","journal-title":"Structure"},{"key":"10.1016\/j.isci.2024.110049_bib16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acsinfecdis.6b00181","article-title":"Structure-Based Targeting of Orthologous Pathogen Proteins Accelerates Antiparasitic Drug Discovery","volume":"3","author":"Jain","year":"2017","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.isci.2024.110049_bib17","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.str.2017.07.015","article-title":"Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis, Cryptosporidiosis, and Coccidiosis","volume":"25","author":"Jain","year":"2017","journal-title":"Structure"},{"key":"10.1016\/j.isci.2024.110049_bib18","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1107\/S2053230X19014808","article-title":"Conformational heterogeneity in apo and drug-bound structures of Toxoplasma gondii prolyl-tRNA synthetase","volume":"75","author":"Mishra","year":"2019","journal-title":"Acta Crystallogr. F Struct. Biol. Commun."},{"key":"10.1016\/j.isci.2024.110049_bib19","doi-asserted-by":"crossref","first-page":"eaba8412","DOI":"10.1126\/scitranslmed.aba8412","article-title":"Bicyclic azetidines kill the diarrheal pathogen Cryptosporidium in mice by inhibiting parasite phenylalanyl-tRNA synthetase","volume":"12","author":"Vinayak","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2024.110049_bib20","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1002\/cbic.202100212","article-title":"Inhibition of Plasmodium falciparum Lysyl-tRNA synthetase via a piperidine-ring scaffold inspired Cladosporin analogues","volume":"22","author":"Babbar","year":"2021","journal-title":"Chembiochem"},{"key":"10.1016\/j.isci.2024.110049_bib21","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature19804","article-title":"Diversity-oriented synthesis yields novel multistage antimalarial inhibitors","volume":"538","author":"Kato","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.isci.2024.110049_bib22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1021\/acsinfecdis.6b00078","article-title":"Biochemical and structural characterization of selective allosteric inhibitors of the Plasmodium falciparum drug target, prolyl-tRNA-synthetase","volume":"3","author":"Hewitt","year":"2017","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.isci.2024.110049_bib23","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41467-020-20478-5","article-title":"Structural basis of malaria parasite phenylalanine tRNA-synthetase inhibition by bicyclic azetidines","volume":"12","author":"Sharma","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2024.110049_bib24","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.ijbiomac.2018.09.115","article-title":"Structural and functional analysis of Glutaminyl-tRNA synthetase (TtGlnRS) from Thermus thermophilus HB8 and its complexes","volume":"120","author":"Nachiappan","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.isci.2024.110049_bib25","doi-asserted-by":"crossref","first-page":"7015","DOI":"10.1073\/pnas.1814685116","article-title":"Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis","volume":"116","author":"Baraga\u00f1a","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2024.110049_bib26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41467-022-28108-y","article-title":"Bicyclic azetidines target acute and chronic stages of Toxoplasma gondii by inhibiting parasite phenylalanyl t-RNA synthetase","volume":"13","author":"Radke","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2024.110049_bib27","doi-asserted-by":"crossref","first-page":"4976","DOI":"10.1038\/s41467-022-32630-4","article-title":"Elucidating the path to Plasmodium prolyl-tRNA synthetase inhibitors that overcome halofuginone resistance","volume":"13","author":"Tye","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2024.110049_bib28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nature11774","article-title":"ATP-directed capture of bioactive herbal-based medicine on human tRNA synthetase","volume":"494","author":"Zhou","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.isci.2024.110049_bib29","doi-asserted-by":"crossref","first-page":"e1010363","DOI":"10.1371\/journal.ppat.1010363","article-title":"Double drugging of prolyl-TRNA synthetase provides a new paradigm for anti-infective drug development","volume":"18","author":"Manickam","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.isci.2024.110049_bib30","doi-asserted-by":"crossref","first-page":"e0186587","DOI":"10.1371\/journal.pone.0186587","article-title":"Discovery and pharmacological characterization of a new class of prolyl-tRNA synthetase inhibitor for anti-fibrosis therapy","volume":"12","author":"Shibata","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2024.110049_bib31","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1016\/j.drudis.2022.05.020","article-title":"Prospects of halofuginone as an antiprotozoal drug scaffold","volume":"27","author":"Gill","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.isci.2024.110049_bib32","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.bbrc.2017.05.064","article-title":"Discovery of a novel prolyl-tRNA synthetase inhibitor and elucidation of its binding mode to the ATP site in complex with L-proline","volume":"488","author":"Adachi","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.isci.2024.110049_bib33","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1021\/acsinfecdis.1c00020","article-title":"Repositioning and Characterization of 1-(Pyridin-4-yl)pyrrolidin-2-one Derivatives as Plasmodium Cytoplasmic Prolyl-tRNA Synthetase Inhibitors","volume":"7","author":"Okaniwa","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.isci.2024.110049_bib34","doi-asserted-by":"crossref","first-page":"e1011124","DOI":"10.1371\/journal.ppat.1011124","article-title":"Targeting prolyl-tRNA synthetase via a series of ATP-mimetics to accelerate drug discovery against toxoplasmosis","volume":"19","author":"Yogavel","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.isci.2024.110049_bib35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nature11774","article-title":"ATP-directed capture of bioactive herbal-based medicine on human tRNA synthetase","volume":"494","author":"Zhou","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.isci.2024.110049_bib36","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.bcp.2018.06.009","article-title":"Aminoacyl-tRNA synthetases, therapeutic targets for infectious diseases","volume":"154","author":"Lee","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.isci.2024.110049_bib37","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41573-019-0026-3","article-title":"Aminoacyl-tRNA synthetases as therapeutic targets","volume":"18","author":"Kwon","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2024.110049_bib38","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1074\/jbc.REV118.002956","article-title":"Progress and challenges in aminoacyl-tRNA synthetase-based therapeutics","volume":"294","author":"Francklyn","year":"2019","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2024.110049_bib39","doi-asserted-by":"crossref","first-page":"e0007983","DOI":"10.1371\/journal.pntd.0007983","article-title":"Targeting tRNA-synthetase interactions towards novel therapeutic discovery against eukaryotic pathogens","volume":"14","author":"Kelly","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.isci.2024.110049_bib40","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10969-014-9182-1","article-title":"Structural basis of malaria parasite lysyl-tRNA synthetase inhibition by cladosporin","volume":"15","author":"Khan","year":"2014","journal-title":"J.\u00a0Struct. Funct. Genomics"},{"key":"10.1016\/j.isci.2024.110049_bib41","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.str.2015.02.011","article-title":"Structure of prolyl-tRNA synthetase-halofuginone complex provides basis for development of drugs against malaria and toxoplasmosis","volume":"23","author":"Jain","year":"2015","journal-title":"Structure"},{"key":"10.1016\/j.isci.2024.110049_bib42","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.bbrc.2017.01.045","article-title":"Prolyl-tRNA synthetase inhibition promotes cell death in SK-MEL-2 cells through GCN2-ATF4 pathway activation","volume":"488","author":"Arita","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.isci.2024.110049_bib43","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0003-2697(88)90484-8","article-title":"A malachite green procedure for orthophosphate determination and its use in alkaline phosphatase-based enzyme immunoassay","volume":"171","author":"Baykov","year":"1988","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.isci.2024.110049_bib44","doi-asserted-by":"crossref","first-page":"572644","DOI":"10.7554\/eLife.57264","article-title":"How to measure and evaluate binding affinities","volume":"9","author":"Jarmoskaite","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.isci.2024.110049_bib45","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human malaria parasites in continuous culture","volume":"193","author":"Trager","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.isci.2024.110049_bib46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.molbiopara.2004.05.009","article-title":"Localization of organellar proteins in Plasmodium falciparum using a novel set of transfection vectors and a new immunofluorescence fixation method","volume":"137","author":"Tonkin","year":"2004","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.isci.2024.110049_bib47","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","article-title":"Simple and Inexpensive Fluorescence-Based Technique for High-Throughput Antimalarial Drug Screening","volume":"48","author":"Smilkstein","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.isci.2024.110049_bib48","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1107\/S2059798317017235","article-title":"DIALS : implementation and evaluation of a new integration package","volume":"74","author":"Winter","year":"2018","journal-title":"Acta Crystallogr. Sect. D Struct. Biol."},{"key":"10.1016\/j.isci.2024.110049_bib49","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J.\u00a0Appl. Crystallogr."},{"key":"10.1016\/j.isci.2024.110049_bib50","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: A comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"10.1016\/j.isci.2024.110049_bib51","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: Model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.isci.2024.110049_bib52","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/pro.3330","article-title":"MolProbity: More and better reference data for improved all-atom structure validation","volume":"27","author":"Williams","year":"2018","journal-title":"Protein Sci."},{"issue":"W1","key":"10.1016\/j.isci.2024.110049_bib53","doi-asserted-by":"crossref","first-page":"W530","DOI":"10.1093\/nar\/gkab294","article-title":"PLIP 2021: expanding the scope of the protein-ligand interaction profiler to DNA and RNA","volume":"49","author":"Adasme","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.isci.2024.110049_bib54","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J.\u00a0Comput. Chem."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224012744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224012744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T04:48:35Z","timestamp":1747457315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004224012744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":54,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2589004224012744"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2024.110049","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ATP mimetics targeting prolyl-tRNA synthetases as a new avenue for antimalarial drug development","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2024.110049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110049"}}